Ms. Caroline D. Dorsa is an Independent Director at Duke Energy Corp., an Independent Trustee at Goldman Sachs Credit Income Fund, an Independent Trustee at Goldman Sachs Real Estate Diversified Income Fund, an Independent Director at Illumina, Inc., an Independent Trustee at Goldman Sachs MLP & Energy Renaissance Fund, a Director Emeritus at Institute For Advanced Clinical Trials For Children, an Independent Director at Intellia Therapeutics, Inc. and an Independent Director at Biogen, Inc.

She is on the Board of Directors at Duke Energy Corp., Goldman Sachs Credit Income Fund, Goldman Sachs Real Estate Diversified Income Fund, Illumina, Inc., Goldman Sachs MLP & Energy Renaissance Fund, Goldman Sachs ETF Trust, Institute For Advanced Clinical Trials For Children, Intellia Therapeutics, Inc., Biogen, Inc. and Biogen GmbH. Ms. Dorsa was previously employed as a Trustee by Goldman Sachs MLP Income Opportunities Fund, a Chief Financial Officer by PSEG Energy Holdings LLC, a Chief Financial Officer, Director & Executive VP by PSEG Power LLC, a Chief Financial Officer & Executive Vice President by PSEG Services Corp., a Chief Financial Officer & Executive Vice President by Public Service Electric & Gas Co., a Chief Financial Officer & Senior Vice President by Gilead Sciences, Inc., a Chief Financial Officer & Senior Vice President by Avaya, Inc., a Chief Financial Officer & Executive Vice President by Public Service Enterprise Group, Inc., a SVP-Global Human, Health, Strategy & Integration by Merck & Co., Inc., a Trustee by Goldman Sachs Private Markets Fund 2018 (B) LLC, a Trustee by Goldman Sachs Private Markets Fund 2018 LLC, and a Trustee by The Newark Museum of Art.

She also served on the board at Joule Unlimited Technologies, Inc., Junior Achievement of New Jersey, Inc. and Biogen Idec New Ventures, Inc.

She received her undergraduate degree from Colgate University and an MBA from Columbia Business School.